KDA Group (TSXV:KDA) Total Stockholders Equity: C$5.99 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is KDA Group Total Stockholders Equity?

KDA Group TSXV:KDA +14.29% Total Stockholders Equity is C$5.99 Mil as of Apr. 2026. The stock has 3 warning signs investors should review.

KDA Group's Total Stockholders Equity for the quarter that ended in Apr. 2026 was C$5.99 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. KDA Group's Book Value per Share for the quarter that ended in Apr. 2026 was C$0.03. The ratio of a company's debt over equity can be used to measure how leveraged this company is. KDA Group's Debt-to-Equity for the quarter that ended in Apr. 2026 was 0.10.


KDA Group  (TSXV:KDA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

KDA Group's Book Value per Share for the quarter that ended in Apr. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

KDA Group's Debt-to-Equity for the quarter that ended in Apr. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


KDA Group Total Stockholders Equity Related Terms


KDA Group Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for KDA Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KDA Group Total Stockholders Equity Chart

KDA Group Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.91 -0.20 16.51 12.50 10.87

KDA Group Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.02 10.87 9.73 9.23 5.99
What does a Total Stockholders Equity of C$5.99 Mil mean?
KDA Group (TSXV:KDA) has a Total Stockholders Equity of C$5.99 Mil as of Apr. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for KDA Group and its competitors.
Is KDA Group's Total Stockholders Equity too high?
KDA Group's current Total Stockholders Equity is C$5.99 Mil.
How does KDA Group's Total Stockholders Equity compare to VEEV and BTSG?
KDA Group's Total Stockholders Equity of C$5.99 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for KDA Group and its competitors. KDA Group's current Total Stockholders Equity is C$5.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDA Group stock overvalued right now?
KDA Group (TSXV:KDA) has a current Total Stockholders Equity of C$5.99 Mil. The current Total Stockholders Equity is C$5.99 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For KDA Group (TSXV:KDA), the current Total Stockholders Equity is C$5.99 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

KDA Group Business Description

Other Exchanges KDAGF:USAO1M:Germany
Address 1351 Notre-Dame East, Suite 300, Thetford Mines, QC, CAN, G6G 0G5
KDA Group Inc provides technological and operational efficiency solutions for general and specialized health sectors through its technology platform, which includes electronic prescription platforms for Canada and the United States and Adherize and Medherize functionalities for pharmaceutical adherence and oncology-focused therapeutic monitoring. The company operates through two segments: Pharmaceutical Technology and Corporate.